Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems (AEHR) director Rhea J. Posedel has filed a Form 4 reporting the grant of 10,575 restricted stock units (RSUs) on 07/02/2025. The RSUs carry no cash exercise price and will vest in equal eighths at the end of each three-month period, contingent on continued board service. Following the award, the director’s direct ownership rises to 71,163 shares, while an additional 470,977 shares are held indirectly through a trust, bringing total beneficial ownership above 542,000 shares.
The filing also references earlier ESOP plan distributions that are already reflected in the current share count and do not constitute new market transactions. No derivative securities were exercised or disposed of, and there were no open-market purchases or sales disclosed. While RSU grants are routine board compensation, the increased equity stake further aligns the director’s interests with shareholders.
- Transaction type: RSU award (code “A”)
- Shares acquired: 10,575
- Total direct shares after grant: 71,163
- Total indirect shares: 470,977 (via trust)
- Vesting: 1/8 every three months
No price was paid for the RSUs, and the filing is unlikely to be materially market-moving on its own, though it signals continued long-term commitment from a key board member.